In conclusion, our data suggest that the use IFN (rather than the PI) has a deleterious effect on neutrophil and monocyte phagocytic and oxidative burst capacity in patients with hepatitis C-related advanced liver fibrosis receiving antiviral therapy. The gene discussed is IFNA1; the disease is hepatitis C virus infection.